Subjective valuation of Iranian women for screening for gene-related diseases: a case of breast cancer

Abstract Background About 5–10% of breast cancer cases are attributed to a gene mutation. To perform preventive interventions for women with a gene mutation, genetic screening BRCA tests have recently been implemented in Iran. The present study aimed to determine Iranian women’s subjective valuation...

Full description

Bibliographic Details
Main Authors: Zahra Meshkani, Najmeh Moradi, Ali Aboutorabi, Abdosaleh Jafari, Roshanak Shams
Format: Article
Language:English
Published: BMC 2023-04-01
Series:BMC Public Health
Subjects:
Online Access:https://doi.org/10.1186/s12889-023-15568-0
_version_ 1797845778144690176
author Zahra Meshkani
Najmeh Moradi
Ali Aboutorabi
Abdosaleh Jafari
Roshanak Shams
author_facet Zahra Meshkani
Najmeh Moradi
Ali Aboutorabi
Abdosaleh Jafari
Roshanak Shams
author_sort Zahra Meshkani
collection DOAJ
description Abstract Background About 5–10% of breast cancer cases are attributed to a gene mutation. To perform preventive interventions for women with a gene mutation, genetic screening BRCA tests have recently been implemented in Iran. The present study aimed to determine Iranian women’s subjective valuation for screening BRCA tests for early detection of breast cancer to help policymakers to make decisions about genetic screening tests for breast cancer and to know the applicants. Methods An online survey was completed by women older than 30 years old in Tehran, the capital of Iran in 2021. A hypothetical scenario about genetic screening tests for breast cancer was defined. The subjective valuation for the tests was assessed by a willingness to pay (WTP) using the contingent valuation method (CVM) by payment card. Demographics, history of breast cancers, knowledge, and physiological variables were considered as independent variables, and a logistic regression model assessed the relationship between WTP and the variables. Results 660 women were included. 88% of participants intended to participate in BRCA genetic screening for breast cancer if it were free. The mean WTP for the tests was about $ 20. Based on the logistic regression, income, family history of breast or ovarian cancer, and positive attitude were associated with WTP. Conclusions Iranian women were willing to intend for genetic screening BRCA tests and pay for them as well. The result of the present study is of great importance for policy makers when it comes to funding and determining co-payments for BRCA genetic screening tests. To achieve a high participation rate of women in breast cancer screening plans, a positive attitude should be promoted as a psychological factor. Educational and informative programs can help.
first_indexed 2024-04-09T17:44:25Z
format Article
id doaj.art-ea3b60132dd449eb859fa50fc687b75c
institution Directory Open Access Journal
issn 1471-2458
language English
last_indexed 2024-04-09T17:44:25Z
publishDate 2023-04-01
publisher BMC
record_format Article
series BMC Public Health
spelling doaj.art-ea3b60132dd449eb859fa50fc687b75c2023-04-16T11:27:22ZengBMCBMC Public Health1471-24582023-04-012311910.1186/s12889-023-15568-0Subjective valuation of Iranian women for screening for gene-related diseases: a case of breast cancerZahra Meshkani0Najmeh Moradi1Ali Aboutorabi2Abdosaleh Jafari3Roshanak Shams4Department of Health Economics, School of Health Management and Information Science, Iran University of Medical SciencesPopulation Health Sciences Institute, Newcastle UniversityDepartment of Health Economics, School of Health Management and Information Science, Iran University of Medical SciencesHealth Human Resources Research Center, School of health Management and Information Sciences, Shiraz University of Medical sciencesBone and Joint Reconstruction Research center, Department of Orthopedics, School of Medicine, Iran University of Medical SciencesAbstract Background About 5–10% of breast cancer cases are attributed to a gene mutation. To perform preventive interventions for women with a gene mutation, genetic screening BRCA tests have recently been implemented in Iran. The present study aimed to determine Iranian women’s subjective valuation for screening BRCA tests for early detection of breast cancer to help policymakers to make decisions about genetic screening tests for breast cancer and to know the applicants. Methods An online survey was completed by women older than 30 years old in Tehran, the capital of Iran in 2021. A hypothetical scenario about genetic screening tests for breast cancer was defined. The subjective valuation for the tests was assessed by a willingness to pay (WTP) using the contingent valuation method (CVM) by payment card. Demographics, history of breast cancers, knowledge, and physiological variables were considered as independent variables, and a logistic regression model assessed the relationship between WTP and the variables. Results 660 women were included. 88% of participants intended to participate in BRCA genetic screening for breast cancer if it were free. The mean WTP for the tests was about $ 20. Based on the logistic regression, income, family history of breast or ovarian cancer, and positive attitude were associated with WTP. Conclusions Iranian women were willing to intend for genetic screening BRCA tests and pay for them as well. The result of the present study is of great importance for policy makers when it comes to funding and determining co-payments for BRCA genetic screening tests. To achieve a high participation rate of women in breast cancer screening plans, a positive attitude should be promoted as a psychological factor. Educational and informative programs can help.https://doi.org/10.1186/s12889-023-15568-0Breast cancerGenetic screening testBRCAWillingness to pay (WTP)Iran
spellingShingle Zahra Meshkani
Najmeh Moradi
Ali Aboutorabi
Abdosaleh Jafari
Roshanak Shams
Subjective valuation of Iranian women for screening for gene-related diseases: a case of breast cancer
BMC Public Health
Breast cancer
Genetic screening test
BRCA
Willingness to pay (WTP)
Iran
title Subjective valuation of Iranian women for screening for gene-related diseases: a case of breast cancer
title_full Subjective valuation of Iranian women for screening for gene-related diseases: a case of breast cancer
title_fullStr Subjective valuation of Iranian women for screening for gene-related diseases: a case of breast cancer
title_full_unstemmed Subjective valuation of Iranian women for screening for gene-related diseases: a case of breast cancer
title_short Subjective valuation of Iranian women for screening for gene-related diseases: a case of breast cancer
title_sort subjective valuation of iranian women for screening for gene related diseases a case of breast cancer
topic Breast cancer
Genetic screening test
BRCA
Willingness to pay (WTP)
Iran
url https://doi.org/10.1186/s12889-023-15568-0
work_keys_str_mv AT zahrameshkani subjectivevaluationofiranianwomenforscreeningforgenerelateddiseasesacaseofbreastcancer
AT najmehmoradi subjectivevaluationofiranianwomenforscreeningforgenerelateddiseasesacaseofbreastcancer
AT aliaboutorabi subjectivevaluationofiranianwomenforscreeningforgenerelateddiseasesacaseofbreastcancer
AT abdosalehjafari subjectivevaluationofiranianwomenforscreeningforgenerelateddiseasesacaseofbreastcancer
AT roshanakshams subjectivevaluationofiranianwomenforscreeningforgenerelateddiseasesacaseofbreastcancer